The ability of boosting the leptin level and reducing the lipid metabolism by the high-dose spirulina implicates the potential therapeutic application for clinical obesity management (Carlier et al., 2010; Brown et al., 2014; Coello et al., 2019). This evidence concerns the gene LEP and obesity disorder.